The following pages link to Stefania Paolucci (Q73036195):
Displayed 50 items.
- Genetic divergence of influenza A NS1 gene in pandemic 2009 H1N1 isolates with respect to H1N1 and H3N2 isolates from previous seasonal epidemics (Q30393218) (← links)
- Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. (Q33758603) (← links)
- The PDZ-ligand and Src-homology type 3 domains of epidemic avian influenza virus NS1 protein modulate human Src kinase activity during viral infection. (Q34081828) (← links)
- Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. (Q34149154) (← links)
- Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement (Q35069514) (← links)
- Assays for determination of HIV resistance to antiviral drugs. (Q35867094) (← links)
- Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A. (Q36525347) (← links)
- Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection (Q36576849) (← links)
- Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients (Q37426527) (← links)
- Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages (Q37427096) (← links)
- Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group (Q37530942) (← links)
- Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy (Q38972095) (← links)
- Development and persistence of DAA resistance associated mutations in patients failing HCV treatment (Q39337307) (← links)
- Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group (Q39501143) (← links)
- Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. (Q39519625) (← links)
- Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life. (Q40241218) (← links)
- HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy. (Q40373017) (← links)
- Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter--spring season. (Q40397174) (← links)
- Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication. (Q40425060) (← links)
- First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing. (Q40870028) (← links)
- The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. (Q41347441) (← links)
- Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation (Q41725485) (← links)
- HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. (Q42094831) (← links)
- Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy. (Q42214894) (← links)
- Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir. (Q43199937) (← links)
- Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility. (Q43482398) (← links)
- Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009. (Q43520841) (← links)
- Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART. (Q43630493) (← links)
- Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity. (Q44324702) (← links)
- Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy. (Q45360877) (← links)
- NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine. (Q45401764) (← links)
- Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. (Q45729780) (← links)
- Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. (Q45757961) (← links)
- Occurrence of Extended Spectrum β-Lactamases, KPC-Type, and MCR-1.2-Producing Enterobacteriaceae from Wells, River Water, and Wastewater Treatment Plants in Oltrepò Pavese Area, Northern Italy. (Q46253963) (← links)
- Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs (Q47121746) (← links)
- Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? (Q47633959) (← links)
- Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons. Brief report. (Q47772700) (← links)
- Novel recombinant phenotypic assay for clonal analysis of reverse transcriptase mutations conferring drug resistance to HIV-1 variants. (Q47881442) (← links)
- Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. (Q50552089) (← links)
- 12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis. (Q51745126) (← links)
- HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. (Q51965374) (← links)
- Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART. (Q52019344) (← links)
- Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients. (Q54044327) (← links)
- Quantification and identification of polyomavirus DNA in blood and urine of renal transplant recipients. (Q54579991) (← links)
- Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. (Q55379857) (← links)
- Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates (Q57275303) (← links)
- Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients (Q57275309) (← links)
- Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns (Q57275310) (← links)
- Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) (Q58388866) (← links)
- Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C (Q59350177) (← links)